These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10705875)

  • 41. Metabolic clearance and production rates of prolactin in man.
    Cooper DS; Ridgway EC; Kliman B; Kjellberg RN; Maloof F
    J Clin Invest; 1979 Dec; 64(6):1669-80. PubMed ID: 583048
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hyperprolactinemia in systemic lupus erythematosus?
    Ostendorf B; Fischer R; Santen R; Schmitz-Linneweber B; Specker C; Schneider M
    Scand J Rheumatol; 1996; 25(2):97-102. PubMed ID: 8614774
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunohistochemical detection of glycoprotein hormone alpha subunit in somatoprolactinic and pure somatotroph adenomas.
    Vantyghem MC; Cortet C; Bauters C; Gevaert MH; Dewailly D; Lefebvre J; Mazzucca M
    J Endocrinol Invest; 1998; 21(7):434-40. PubMed ID: 9766257
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in the prolactin serum isoforms secreted by a pituitary adenoma associated with therapy.
    Morán C; Tena G; Fonseca ME; Ochoa R; Bermúdez JA; Zárate A
    Arch Med Res; 1994; 25(1):1-3. PubMed ID: 8019107
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of dopaminergic tone in hyperprolactinemia. III. Thyroid-stimulating hormone response to metoclopramide in differential diagnosis and postoperative follow-up of prolactinoma patients.
    De Marinis L; Mancini A; Minnielli S; Masala R; Anile C; Maira G; Barbarino A
    Metabolism; 1985 Oct; 34(10):917-22. PubMed ID: 4046835
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dynamics of prolactin secretion in patients with hypopituitarism and pituitary macroadenomas.
    Arafah BM; Nekl KE; Gold RS; Selman WR
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3507-12. PubMed ID: 8530591
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of N-methyl-D-aspartic acid and kainic acid on prolactin secretion in hyper- and hypoprolactinaemic conditions.
    Pinilla L; Tena-Sempere M; Aguilar R; Aguilar E
    Eur J Endocrinol; 1998 Apr; 138(4):460-6. PubMed ID: 9578517
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The proportion of glycosylated prolactin in serum is decreased in hyperprolactinemic states.
    Hashim IA; Aston R; Butler J; McGregor AM; Smith CR; Norman M
    J Clin Endocrinol Metab; 1990 Jul; 71(1):111-5. PubMed ID: 2370290
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polycystic ovary syndrome and hyperprolactinemia are distinct entities.
    Filho RB; Domingues L; Naves L; Ferraz E; Alves A; Casulari LA
    Gynecol Endocrinol; 2007 May; 23(5):267-72. PubMed ID: 17558684
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Macroprolactinemia: a new cause of hyperprolactinemia.
    Hattori N
    J Pharmacol Sci; 2003 Jul; 92(3):171-7. PubMed ID: 12890882
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of stress on serum prolactin levels in patients with systemic lupus erythematosus.
    Dostál C; Marek J; Moszkorzová L; Lacinová Z; Musilová L; Zvarová J
    Ann N Y Acad Sci; 2002 Jun; 966():247-51. PubMed ID: 12114279
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prolactin in men's health and disease.
    Bolyakov A; Paduch DA
    Curr Opin Urol; 2011 Nov; 21(6):527-34. PubMed ID: 21941183
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of anti-PRL (prolactin) autoantibodies by homologous PRL in rats: a model for macroprolactinemia.
    Hattori N; Nakayama Y; Kitagawa K; Li T; Inagaki C
    Endocrinology; 2007 May; 148(5):2465-70. PubMed ID: 17303669
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prolactin as a Potential Early Predictive Factor in Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab.
    Caponnetto S; Iannantuono GM; Barchiesi G; Magri V; Gelibter A; Cortesi E
    Oncology; 2017; 93(1):62-66. PubMed ID: 28407622
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Macroprolactin: what is it and what is its importance?
    Sadideen H; Swaminathan R
    Int J Clin Pract; 2006 Apr; 60(4):457-61. PubMed ID: 16620360
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prolactin-secreting adenomas: surgical results and long-term follow-up.
    Maira G; Anile C; De Marinis L; Barbarino A
    Neurosurgery; 1989 May; 24(5):736-43. PubMed ID: 2716983
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tests of prolactin secretion in the diagnosis of hyperprolactinemic states: nomifensine and domperidone.
    Massara F; Genazzani AR; Camanni F; De Leo V; Molinatti GM; Müller EE
    Fertil Steril; 1981 Feb; 35(2):149-54. PubMed ID: 7202740
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lack of plasma prolactin response to intravenously injected vasoactive intestinal polypeptide in patients with prolactin-secreting adenoma.
    Kaji H; Chihara K; Kita T; Kashio Y; Okimura Y; Fujita T
    Acta Endocrinol (Copenh); 1985 Dec; 110(4):445-50. PubMed ID: 4090907
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of anti-prolactin autoantibodies on serum prolactin measurements.
    Hattori N; Ikekubo K; Ishihara T; Moridera K; Hino M; Kurahachi H
    Eur J Endocrinol; 1994 May; 130(5):434-7. PubMed ID: 8180668
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum prolactin concentrations in male patients with rheumatoid arthritis.
    Seriolo B; Ferretti V; Sulli A; Fasciolo D; Cutolo M
    Ann N Y Acad Sci; 2002 Jun; 966():258-62. PubMed ID: 12114281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.